UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
ByTokujiro Yano, MD,Shoji Kudoh, MD,Kozo Yoshimori, MD,Tetsuyuki Morikawa, MD,Mutsuo Kuba, MD,Hisanobu Niitani, MD
Published: | Updated:
A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-